Immunovant Inc

Stock Chart, Company Information, and Scan Results

$16.49(as of Sep 4, 1:39 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Immunovant Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$16.49
Ticker SymbolIMVT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees362
CountyUSA
Market Cap$2,627.0M
EBIDTA-470.7M
10-Day Moving Average15.13
P/E Ratio-6.38
20-Day Moving Average15.24
Forward P/E Ratio0.00
50-Day Moving Average16.30
Earnings per Share-2.84
200-Day Moving Average19.10
Profit Margin-Infinity%
RSI60.52
Shares Outstanding174.3M
ATR0.74
52-Week High34.47
Volume4,327,086
52-Week Low12.72
Most Recent Support Level14.47
Book Value608.5M
Most Recent Resistance Level15.39
P/B Ratio4.69
Upper Keltner16.91
P/S Ratio17,834.87
Lower Keltner13.57
Debt-to-Equity Ratio16.91
Next Earnings Date10/31/2025
Cash Surplus546.0M
Next Ex-Dividend DateUnknown

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant Inc In Our Stock Scanner

As of Sep 04, 2025
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.